Stem Cells and Disease Modelling
Stem cells offer a powerful platform for modeling human diseases in the laboratory, providing researchers with valuable tools to study disease mechanisms, identify novel therapeutic targets, and develop more effective treatments. By reprogramming adult cells into induced pluripotent stem cells (iPSCs), scientists can generate patient-specific cell lines that carry the genetic mutations associated with a particular disease. These iPSCs can then be differentiated into disease-relevant cell types, such as neurons for neurological disorders, cardiomyocytes for heart diseases, or hepatocytes for liver disorders. This approach allows researchers to recapitulate key aspects of disease pathology in a controlled, laboratory setting.
Stem cell-based disease models enable researchers to:
- Study Disease Mechanisms
- Screen for Drug Candidates
- Personalized Medicine
- Disease Monitoring and Biomarker Discovery
Related Conference of Stem Cells and Disease Modelling
21th World Congress on Tissue Engineering Regenerative Medicine and Stem Cell Research
16th International Conference on Human Genetics and Genetic Diseases
19th International Conference on Genomics & Pharmacogenomics
Stem Cells and Disease Modelling Conference Speakers
Recommended Sessions
- Dental Stem Cells
- Bio Banking Stem cell
- Bone Marrow Transplantation
- Cell and Genetic Therapy
- Clinical Methods
- Neurodegenerative Disease
- Stem Cell & Regenerative Drugs
- Stem Cell Animal Applications
- Stem Cell Apoptosis
- Stem Cell Embryology
- Stem Cell in Cardiovascular Disease
- Stem Cell Therapy
- Stem Cells and Disease Modelling
- Stem Cells in Drug Discovery
- Tissue Engineering
- Translational Research in Stem Cell
Related Journals
Are you interested in
- Artificial Intelligence and Computational Biology in Regenerative Medicine - Stemgen 2026 (Japan)
- Biomaterials and Nanotechnology in Regenerative Medicine - Stemgen 2026 (Japan)
- Cancer Stem Cells and Oncology - Stemgen 2026 (Japan)
- Cardiovascular Regeneration - Stemgen 2026 (Japan)
- Clinical Trials and Translational Stem Cell Research - Stemgen 2026 (Japan)
- Ethical, Legal, and Social Implications in Stem Cell Research - Stemgen 2026 (Japan)
- Future Trends: Organoids, Bioengineering, and Next-Generation Therapies - Stemgen 2026 (Japan)
- Gene Editing and CRISPR Technologies - Stemgen 2026 (Japan)
- Induced Pluripotent Stem Cells (iPSCs) and Reprogramming - Stemgen 2026 (Japan)
- Mesenchymal Stem Cells (MSCs) in Therapy - Stemgen 2026 (Japan)
- Regenerative Dentistry and Craniofacial Applications - Stemgen 2026 (Japan)
- Regenerative Medicine and Tissue Engineering - Stemgen 2026 (Japan)
- Stem Cell Banking and Cryopreservation - Stemgen 2026 (Japan)
- Stem Cell Biology and Cellular Mechanisms - Stemgen 2026 (Japan)
- Stem Cells in Neurological and Neurodegenerative Disorders - Stemgen 2026 (Japan)
